Kite Pharma, Inc.
Overview
Kite Pharma, a Gilead Company, is a biopharmaceutical company that specializes in the development of innovative cancer immunotherapies. Focused on chimeric antigen receptor (CAR) T cell therapies, Kite is committed to advancing breakthrough treatments for patients with hematological cancers.
Therapeutic areas
FDA compliance signals
7 FDA enforcement records linked to this company.
- 4832025-08-27
Written sanitation procedures lacking
- 4832025-08-27
input/output verification
- 4832025-08-27
Written record of investigation incomplete
- 4832025-08-27
Absence of Written Procedures
- 4832021-10-22
Environmental Monitoring System
- 4832019-08-20
SOPs not followed / documented
- 4832019-08-20
Test methods
Related companies
Adventris Pharmaceuticals
United States
Alpha Oncology Therapeutics, Inc.
USA
Aulos Bioscience, Inc.
United States
Cancer Research Innovations, Inc.
USA
Checkpoint Therapeutics, Inc.
United States
Eureka Therapeutics, Inc.
United States
Fate Therapeutics, Inc.
United States
Fred Hutchinson Cancer Center
United States
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.